These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30333119)

  • 1. How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms.
    Odenike O
    Blood; 2018 Nov; 132(22):2339-2350. PubMed ID: 30333119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It.
    Patel AA; Odenike O
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):303-309. PubMed ID: 36907766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?
    Kundranda MN; Tibes R; Mesa RA
    Curr Hematol Malig Rep; 2012 Mar; 7(1):78-86. PubMed ID: 22170483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics of MPN progression.
    Patel AA; Odenike O
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):440-449. PubMed ID: 33275731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary acute myeloid leukemias arising from Philadelphia chromosome negative myeloproliferative neoplasms: pathogenesis, risk factors, and therapeutic strategies.
    Tallarico M; Odenike O
    Curr Hematol Malig Rep; 2015 Jun; 10(2):112-7. PubMed ID: 25893311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms.
    Abruzzese E; Niscola P
    Expert Rev Hematol; 2020 Dec; 13(12):1349-1359. PubMed ID: 33226274
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms.
    Kaplan JB; Stein BL; McMahon B; Giles FJ; Platanias LC
    EBioMedicine; 2016 Jan; 3():17-25. PubMed ID: 26870834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium.
    Mascarenhas J; Heaney ML; Najfeld V; Hexner E; Abdel-Wahab O; Rampal R; Ravandi F; Petersen B; Roboz G; Feldman E; Podoltsev N; Douer D; Levine R; Tallman M; Hoffman R;
    Leuk Res; 2012 Dec; 36(12):1500-4. PubMed ID: 22938832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and predictors of survival in blast phase myeloproliferative neoplasms.
    Lancman G; Brunner A; Hoffman R; Mascarenhas J; Hobbs G
    Leuk Res; 2018 Jul; 70():49-55. PubMed ID: 29807273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.
    Patel AA; Yoon JJ; Johnston H; Davidson MB; Shallis RM; Chen EC; Burkart M; Oh TS; Iyer SG; Madarang E; Muthiah C; Gross I; Dean R; Kassner J; Viswabandya A; Madero-Marroquin R; Rampal RK; Guru Murthy GS; Bradley T; Abaza Y; Garcia JS; Gupta V; Pettit KM; Cursio JF; Odenike O
    Blood Adv; 2024 Jul; 8(13):3468-3477. PubMed ID: 38739724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential B-lymphoid and myeloid blastic transformation of Philadelphia chromosome-negative myeloproliferative neoplasm.
    Hu AY; Zhou T
    Br J Haematol; 2019 Jan; 184(1):8. PubMed ID: 30407632
    [No Abstract]   [Full Text] [Related]  

  • 14. The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.
    Tam CS; Nussenzveig RM; Popat U; Bueso-Ramos CE; Thomas DA; Cortes JA; Champlin RE; Ciurea SE; Manshouri T; Pierce SM; Kantarjian HM; Verstovsek S
    Blood; 2008 Sep; 112(5):1628-37. PubMed ID: 18566326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
    Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
    Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated and Blast Phase Myeloproliferative Neoplasms.
    Jain T; Rampal RK
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):325-335. PubMed ID: 33641872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
    Bewersdorf JP; Rampal RK
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the challenges of accelerated and blast phase myeloproliferative neoplasms in 2022 and beyond.
    Saha C; Attwell L; Harrison CN; McLornan DP
    Blood Rev; 2022 Sep; 55():100947. PubMed ID: 35241294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPN blast phase: clinical challenge and assessing response.
    Mesa RA; Tibes R
    Leuk Res; 2012 Dec; 36(12):1496-7. PubMed ID: 22999527
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of advanced phase myeloproliferative neoplasms.
    Marcellino B; Mascarenhas J
    Clin Adv Hematol Oncol; 2019 Jul; 17(7):405-411. PubMed ID: 31449507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.